<div class="youtube-replace"><br />
</div>
<div class="youtube-replace"><br />
</div>
<div class="youtube-replace"><br />
</div><img alt="" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/88178515_1740654022138090_r.jpeg" width="100%" />
<div class="youtube-replace"><br />
</div>
<div>I’m writing on behalf of my 38-year-old Son-in-Law Ryan Becker, who is suffering from an unbelievably serious and painful dermatologic condition initially covering over 30% of his skin, now estimated at 60-70%. The lesions also affect mucous membranes, including inside his mouth. Despite extensive diagnostics, admission to ICU at Sacred Heart in Spokane, WA, and examination by a fleet of doctors and specialists, his condition remained a medical mystery.
</div>
<div><br />
</div>
<div>Ryan was urgently flown to the Mayo Clinic in Rochester, MN, where he spent nearly three weeks being evaluated by the Head of Dermatology. Despite their efforts, Ryan’s illness remained undiagnosed, prompting an urgent transfer to the National Institutes of Health Center for Unknown and Undiagnosed Illnesses at Johns Hopkins in Baltimore. Ryan spent another three weeks at Johns Hopkins, where doctors worked extensively to rule out countless potential causes, still without answers.
</div>
<div><br />
</div>
<div>Since this campaign started, Ryan has developed more than 20 additional lesions, rapidly increasing coverage across his body. After exhaustive workups at Johns Hopkins, Ryan was urgently referred to Dr. Alex Ortega at Oregon Health and Science University (OHSU) in Portland, OR—the world’s leading specialist in Pyoderma Gangrenosum (PG). Most doctors encounter only one or two PG patients throughout their careers, but Dr. Ortega sees nearly 40 per month.
</div>
<div><br />
</div>
<div>After examining Ryan, Dr. Ortega confirmed it was by far the most rapid and widespread case of PG he had ever seen. Ryan is also the first known patient in the over 90-year history of the disease to present simultaneously with all three subtypes of PG. Ryan will begin an emergency experimental treatment at OHSU next week. Before starting the treatment, Ryan has had to significantly reduce his steroid dosage over two weeks, unfortunately causing additional bullous-type lesions to appear on his arms and hands. Currently, steroids have only been able to temporarily slow the progression.
</div>
<div><br />
</div>
<div>Beyond this life-threatening illness, Ryan also suffers from severe PTSD due to his previous career as a medic and firefighter, where he experienced profoundly traumatic events.
</div>
<div><br />
</div>
<div>Neither Ryan nor his wife, Mikkel, can return to work in the foreseeable future. Though they currently have health insurance, maintaining coverage and managing future medical expenses pose significant financial challenges. They continue to face substantial ongoing and future costs including travel, home care, childcare for their infant son Atlas, and possible necessary home modifications.
</div>
<div><br />
</div>
<div>This family has always been incredibly generous, consistently offering their help, resources, and compassion to others in need. Now, they urgently need our support.
</div>
<div><br />
</div>
<div>I have stepped in to manage this GoFundMe campaign as Ryan and Mikkel focus on his treatment.
</div>
<div><br />
</div>
<div>Thank you sincerely for your ongoing support, prayers, and compassion.
</div>
<div><br />
</div>
<div>Warm regards,
</div>
<div><br />
</div>
<div>Dr. Marty Becker, DVM.
</div>

Steven Kim

Nancy Lane

Denise Wiley

Margaret Huggins

Mary Rinke

Nancy Loretta Lory Lamkin

Julie Levy

Deborah Kaufman

Anonymous

Support Ryan’s fight against unprecedented deadly disease

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

currencyCode

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

writePath

Stream Notification

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

Native 11.3.0 and above

Influencer - Prod

US fundraisers and US users

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

isCampaignOwner

fundHasInstagramDeepLink

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

userCurrencyCode

Localized Currency

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

Support Ryan’s fight against unprecedented deadly disease

Still $239,132 to go. Help us build momentum.